The history of Viagra, initially marketed by copyright, presents a fascinating case study for backers considering the healthcare arena . Despite its initial success and generation of billions in earnings , the intellectual property lapse has opened the way for alternative medications, greatly diminishing income prospects . This shift raises doubts